Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts $5.57 +0.04 (+0.72%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vir Biotechnology Earnings Summary Upcoming Earnings DateMay. 1After Market ClosesEstimatedConsensus EPS (Feb. 26) -$0.85 Actual EPS (Feb. 26) -$0.76 Beat By $0.09 Actual Revenue (Feb. 26) $12.37MVir Biotechnology issued Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.76, which beat the consensus estimate of -$0.85 by $0.09. Quarterly revenue was reported to be $12.37 million, above the consensus estimate of $8.14 million. With a trailing EPS of -$3.82, Vir Biotechnology's earnings are expected to grow next year, from ($3.92) to ($3.55) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Annual Report (10-K)VIR Upcoming EarningsVir Biotechnology's Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Vir Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vir Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVIR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VIR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Vir Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.09-$0.68-$0.89Q2 20252-$0.95-$0.76-$0.86Q3 20252-$0.88-$0.85-$0.87Q4 20252-$0.87-$0.80-$0.84FY 20258-$3.79-$3.09-$3.44Q1 20261-$0.80-$0.80-$0.80Q2 20261-$0.80-$0.80-$0.80Q3 20261-$0.81-$0.81-$0.81Q4 20261-$0.77-$0.77-$0.77FY 20264($3.18)($3.18)($3.18) Remove Ads Vir Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------2/26/2025Q4 2024-$0.85-$0.76+$0.09-$0.76$8.14M$12.37M10/31/2024Q3 2024-$1.05-$1.56 -$0.51-$1.56$5.54M$2.38M8/1/2024Q2 2024-$0.89-$1.02 -$0.13-$1.02$7.53M$3.08M5/2/2024Q1 2024-$0.99-$0.48+$0.51-$0.48$11.71M$56.38M2/22/2024Q4 2023-$1.14-$0.86+$0.28-$0.86$11.18M$16.80M11/2/2023Q3 2023-$1.21-$1.22 -$0.01-$1.22$12.57M$2.64M8/3/2023Q2 2023-$1.21-$1.45 -$0.24-$1.45$22.39M$3.80M5/4/2023Q1 2023-$0.86-$1.06 -$0.20-$1.06$50.10M$63.00M Vir Biotechnology Earnings - Frequently Asked Questions When is Vir Biotechnology's earnings date? Vir Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on VIR's earnings history. Did Vir Biotechnology beat their earnings estimates last quarter? In the previous quarter, Vir Biotechnology (NASDAQ:VIR) reported ($0.76) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.09. Learn more on analysts' earnings estimate vs. VIR's actual earnings. How can I listen to Vir Biotechnology's earnings conference call? The conference call for Vir Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Vir Biotechnology's conference call transcript? The conference call transcript for Vir Biotechnology's latest earnings report can be read online. Read Transcript How much revenue does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded annual revenue of $63.71 million. How much profit does Vir Biotechnology generate each year? Vir Biotechnology (NASDAQ:VIR) has a recorded net income of -$615.06 million. VIR has generated -$3.82 earnings per share over the last four quarters. What is Vir Biotechnology's EPS forecast for next year? Vir Biotechnology's earnings are expected to grow from ($3.92) per share to ($3.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies RARE Earnings Results AKRO Earnings Results MOR Earnings Results SWTX Earnings Results PTGX Earnings Results CPRX Earnings Results MRUS Earnings Results ALVO Earnings Results APLS Earnings Results SRRK Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:VIR) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIR Stock Free VIR Stock Alerts